Restricted accessResearch articleFirst published online 2021-2
What Do Meta-Analyses Have to Say About the Efficacy of Neurofeedback Applied to Children With ADHD? Review of Previous Meta-Analyses and a New Meta-Analysis
Objective: We reviewed previously published meta-analyses of neurofeedback applied to children with ADHD and conducted a new meta-analysis of randomized controlled trials (RCTs) that updates previous results and incorporates methodological modifications. Method: Searches were carried out through PubMed, Sage, PsycINFO, SpringerLink, and Psicodoc. We used Hedges’ (adjusted) g and a random-effects model. To assess heterogeneity, Q and I2 were calculated. We performed different analyses depending on the control groups, ADHD symptoms, pre- and/or posttreament data used and symptom evaluator. Results: We reviewed seven meta-analyses, and 17 studies were incorporated into the meta-analysis. RCTs support the efficacy of neurofeedback applied to ADHD when most proximal evaluators assess symptoms. Neurofeedback significantly improves inattention symptoms when possibly blinded evaluators assess symptoms. The preliminary results suggest that stimulant medication is more effective than neurofeedback. Conclusion: New RCTs that establish links between ADHD symptom measurements, subjects’ learning after neurofeedback, and neurophysiological measures could improve the quality of the conclusions.
Akutagava-MartinsG. C.RohdeL. A.HutzM. H. (2016). Genetics of attention-deficit/hyperactivity disorder: An update. Expert Review of Neurotherapeutics, 16, 145-156. doi:10.1586/14737175.2016.1130626
2.
American Academy of Pediatrics. (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128, 1007-1022. doi:10.1542/peds.2011-2654
3.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4.
American Psychiatric Association. (2014). Manual diagnóstico y estadístico de los trastornos mentales [Diagnostic and statistical manual of mental disorders] (5th ed.). Madrid, Spain: Editorial Médica Panamericana.
5.
ArnsM.de RidderS.StrehlU.BretelerM.CoenenA. (2009). Efficacy of neurofeedback treatment in ADHD: The effects on inattention, impulsivity and hyperactivity: A meta-analysis. Clinical EEG and Neuroscience, 40, 180-189. doi:10.1177/155005940904000311
6.
ArnsM.HeinrichH.StrehlU. (2014). Evaluation of neurofeedback in ADHD: The long and winding road. Biological Psychology, 95, 108-115. doi:10.1016/j.biopsycho.2013.11.013
7.
*BakhshayeshA. R.HänschS.WyschkonA.RezaiM. R.EsserG. (2011). Neurofeedback in ADHD: A single-blind randomized controlled trial. European Child & Adolescent Psychiatry, 20, 481-491. doi:10.1007/s00787-011-0208-y
8.
BarkleyR. A.MurphyK. R. (1998). Attention-deficit hyperactivity disorder: A clinical workbook. New York, NY: Guilford Press.
9.
*BeauregardM.LévesqueJ. (2006). Functional magnetic resonance imaging investigation of the effects of neurofeedback training on the neural bases of selective attention and response inhibition in children with attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 31(1), 3-20. doi:10.1007/s10484-006-9001-y
10.
*BinkM.van NieuwenhuizenC.PopmaA.BongersI.van BoxtelG. (2015). Behavioral effects of neurofeedback in adolescents with ADHD: A randomized controlled trial. European Child & Adolescent Psychiatry, 24, 1035-1048. doi:10.1007/s00787-014-0655-3
11.
BotellaJ.SánchezJ. (2015). Meta-análisis en ciencias sociales y de la salud [Meta-analysis in social and health sciences]. Madrid, Spain: Editorial Síntesis.
12.
Canadian Attention Deficit Hyperactivity Disorder Resource Alliance. (2011). Canadian ADHD practice guidelines (3rd ed.). Toronto, Ontario: Author.
13.
CayeA.SwansonJ. M.CoghillD.RohdeL. A. (2019). Treatment strategies for ADHD: An evidence-based guide to select optimal treatment. Molecular Psychiatry, 24, 390-408. doi:10.1038/s41380-018-0116-3
14.
Cerrillo-UrbinaA. J.García-HermosoA.Pardo-GuijarroM. J.Sánchez-LópezM.Santos-GómezJ. L.Martínez-VizcaínoV. (2018). The effects of long-acting stimulant and nonstimulant medications in children and adolescents with attention-deficit/hyperactivity disorder: A meta-analysis of randomized controlled trials. Journal of Child and Adolescent Psychopharmacology, 28, 494-507. doi:10.1089/cap.2017.0151
15.
ChildressA. M. D.TranC. (2016). Current investigational drugs for the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Investigational Drugs, 25, 463-474. doi:10.1517/13543784.2016.1147558
16.
The Cochrane Collaboration. (2011). Cochrane handbook for systematic reviews of interventions (Version 5.1.0, updated March2011). Available from www.handbook.cochrane.org
17.
CorteseS.AdamoN.Del GiovaneC.Mohr-JensenC.HayesA. J.CarucciS.. . . CiprianiA. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5, 727-738. doi:10.1016/S2215-0366(18)30269-4
18.
CorteseS.FerrinM.BrandeisD.HoltmannM.AggensteinerP.DaleyD., . . . European ADHD Guidelines Group. (2016). Neurofeedback for attention-deficit/hyperactivity disorder: Meta-Analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child & Adolescent Psychiatry, 55, 444-455.
19.
DuPaulG. J.PowerT. J.AnastopoulosA. D.ReidR. (1998). ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. New York, NY: Guilford Press.
20.
*DuricN. S.AssmusJ.GundersenD.Duric-GolosA.ElgenI. B. (2017). Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: A 6-month follow-up. Nordic Journal of Psychiatry, 71, 386-394. doi:10.1080/08039488.2017.1305446
21.
EvansJ. R. (2007). Handbook of neurofeedback: Dynamics and clinical applications. New York, NY: The Haworth Medical Press.
22.
FabianoG. A.PelhamW. E.ColesE. K.GnagyE. M.Chronis-TuscanoA.O’ConnorB. C. (2009). A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clinical Psychology Review, 29, 129-140. doi:10.1016/j.cpr.2008.11.001
23.
FroehlichT. E.AnixtJ. S.LoeI. M.ChirdkiatgumchaiV.KuanL.GilmanR. C. (2011). Update on environmental risk factors for attention-deficit/hyperactivity disorder. Current Psychiatry Reports, 13, 333-344. doi:10.1007/s11920-011-0221-3
24.
GalloE. F.PosnerJ. (2016). Moving towards causality in attention-deficit hyperactivity disorder: Overview of neural and genetic mechanisms. The Lancet Psychiatry, 3, 555-567. doi:10.1016/S2215-0366(16)00096-1
25.
*GeladéK.JanssenT. W.BinkM.TwiskJ. W.van MourikR.MarasA.OosterlaanJ. (2018). A 6-month follow-up of an RCT on behavioral and neurocognitive effects of neurofeedback in children with ADHD. European Child & Adolescent Psychiatry, 27, 581-593. doi:10.1007/s00787-017-1072-1
26.
*GevenslebenH.HollB.AlbrechtB.VogelC.SchlampD.KratzO.. . . HeinrichH. (2009). Is neurofeedback an efficacious treatment for ADHD? A randomized controlled clinical trial. Journal of Child Psychology and Psychiatry, 50, 780-789. doi:10.1111/j.1469-7610.2008.02033.x
27.
GlassG. V.McGawB.SmithM. L. (1981). Meta-analysis in social research. Newbury Park, CA: SAGE.
28.
GoodeA. P.CoeytauxR. R.MaslowG. R.DavisN.HillS.NamdariB.. . . KemperA. R. (2018). Nonpharmacologic treatments for attention-deficit/hyperactivity disorder: A systematic review. Pediatrics, 141(6), 1-12.
29.
HodgsonK.HutchinsonA. D.DensonL. (2014). Nonpharmacological treatments for ADHD: A meta-analytic review. Journal of Attention Disorders, 18, 275-282. doi:10.1177/1087054712444732
30.
KelleyK.PreacherK. J. (2012). On effect size. Psychological Methods, 17, 137-152. doi:10.1037/a0028086
LaVaqueT. J.HammondD. C.TrudeauD.MonastraV.PerryJ.LehrerP.. . . ShermanR. (2002). Template for developing guidelines for the evaluation of the clinical efficacy of psychophysiological interventions. Journal of Neurotherapy, 6(4), 11-23.
33.
*LiL.YangL.ZhuoC.WangY. (2013). A randomised controlled trial of combined EEG feedback and methylphenidate therapy for the treatment of ADHD. Swiss Medical Weekly, 143, Article w13838. doi:10.4414/smw.2013.13838
34.
*MaurizioS.LiechtiM.HeinrichH.JänckeL.SteinhausenH.WalitzaS.. . . DrechslerR. (2014). Comparing tomographic EEG neurofeedback and EMG biofeedback in children with attention-deficit/hyperactivity disorder. Biological Psychology, 95, 31-44. doi:10.1016/j.biopsycho.2013.10.008
35.
*MeiselV.ServeraM.García-BandaG.CardoE.MorenoI. (2014). Reprint of “Neurofeedback and standard pharmacological intervention in ADHD: A randomized controlled trial with six-month follow-up.”Biological Psychology, 95, 116-125. doi:10.1016/j.biopsycho.2013.09.009
36.
Micoulaud-FranchiJ. A.GeoffroyP. A.FondG.LópezR.BioulacS.PierreP. (2014). EEG neurofeedback treatments in children with ADHD: An updated meta-analysis of randomized controlled trials. Frontiers in Human Neuroscience, 8, Article 906. doi:10.3389/fnhum.2014.00906
37.
Micoulaud-FranchiJ. A.SalvoF.BioulacS.FovetT. (2016). Neurofeedback in attention-deficit/hyperactivity disorder: Efficacy. Journal of the American Academy of Child & Adolescent Psychiatry, 55, 1091-1092.
38.
*MinderF.ZubererA.BrandeisD.DrechslerR. (2018). Informant-related effects of neurofeedback and cognitive training in children with ADHD including a waiting control phase: A randomized-controlled trial. European Child & Adolescent Psychiatry, 27, 1055-1066. doi:10.1007/s00787-018-1116-1
39.
*Moreno-GarcíaI.Meneres-SanchoS.Camacho-VaradeReyC.ServeraM. (2019). A randomized controlled trial to examine the posttreatment efficacy of neurofeedback, behavior therapy, and pharmacology on ADHD measures. Journal of Attention Disorders, 23, 374-383. doi:10.1177/1087054717693371
40.
MorrisS. B. (2008). Estimating effect sizes from pretest-posttest-control group designs. Organizational Research Methods, 11, 364-386. doi:10.1177/1094428106291059
41.
National Institute for Health and Care Excellence. (2018). Attention deficit hyperactivity disorder: Diagnosis and management. Retrieved from https://www.nice.org.uk/guidance/NG87
42.
*OgrimG.HestadK. A. (2013). Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: A randomized pilot study. Journal of Child and Adolescent Psychopharmacology, 23, 448-457. doi:10.1089/cap.2012.0090
43.
RiccioC. A.ReynoldsC. R.LoweP.MooreJ. J. (2002). The continuous performance test: A window on the neural substrates for attention?Archives of Clinical Neuropsychology, 17, 235-272. doi:10.1016/S0887-6177(01)00111-1
44.
SchacharR. (2014). Genetics of attention deficit hyperactivity disorder (ADHD): Recent updates and future prospects. Current Developmental Disorders Reports, 1, 41-49. doi:10.1007/s40474-013-0004-0
45.
SciberrasE.MulraneyM.SilvaD.CoghillD. (2017). Prenatal risk factors and the etiology of ADHD: Review of existing evidence. Current Psychiatry Reports, 19(1), 1. doi:10.1007/s11920-017-0753-2
46.
SharmaA.CoutureJ. (2014). A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Annals of Pharmacotherapy, 48, 209-225. doi:10.1177/1060028013510699
47.
ShimS. H.YoonH. J.BakJ.HahnS. W.KimY. K. (2016). Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 70, 237-244. doi:10.1016/j.pnpbp.2016.04.007
48.
Sonuga-BarkeE. J. S.BrandeisD.CorteseS.DaleyD.FerrinM.HoltmannM.SergeanJ. (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. The American Journal of Psychiatry, 170, 275-289. doi:10.1176/appi.ajp.2012.12070991
49.
Spanish Ministry of Health, Social Policy, and Equality. (2017). Guía de práctica clínica sobre las intervenciones terapéuticas en el trastorno por déficit de atención con hiperactividad (TDAH) [Clinical practice guideline regarding therapeutic interventions in attention deficit hyperactivity disorder (ADHD)]. Retrieved from http://www.guiasalud.es/GPC/GPC_574_TDAH_IACS_compl.pdf
50.
*SteinerN. J.FrenetteE. C.ReneK. M.BrennanR. T.PerrinE. C. (2014). Neurofeedback and cognitive attention training for children with attention-deficit hyperactivity disorder in schools. Journal of Developmental and Behavioral Pediatrics, 35(1), 18-27. doi:10.1097/DBP.0000000000000009
51.
*StrehlU.AggensteinerP.WachtlinD.BrandeisD.AlbrechtB.AranaM.. . . HoltmannM. (2017). Neurofeedback of slow cortical potentials in children with attention-deficit/hyperactivity disorder: A multicenter randomized trial controlling for unspecific effects. Frontiers in Human Neuroscience, 11, Article 135. doi:10.3389/fnhum.2017.00135
52.
*SudnawaK. K.ChirdkiatgumchaiV.RuangdaraganonN.KhongkhatithumC.UdomsubpayakulU.JirayucharoensakS.IsrasenaP. (2018). Effectiveness of neurofeedback versus medication in treatment of ADHD. Pediatrics International, 60, 828-834. doi:10.1111/ped.13641
53.
TaylorJ.WhiteK. R. (1992). An evaluation of alternative methods for computing standardized mean difference effect size. The Journal of Experimental Education, 61, 63-72.
54.
*van Dongen-BoomsmaM.VollebregtM. A.Slaats-WillemseD.BuitelaarJ. K. (2013). A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder. The Journal of Clinical Psychiatry, 74, 821-827.
55.
Van DorenJ.ArnsM.HeinrichH.VollebregtM. A.StrehlU.LooS. K. (2018). Sustained effects of neurofeedback in ADHD: A systematic review and meta-analysis. European Child & Adolescent Psychiatry. Advance online publication. doi:10.1007/s00787-018-1121-4
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
